HCPCS Codes for Medical care


  • A2001

    Innovamatrix ac, per square centimeter
  • A2002

    Mirragen advanced wound matrix, per square centimeter
  • A2004

    Xcellistem, 1 mg
  • A2005

    Microlyte matrix, per square centimeter
  • A2006

    Novosorb synpath dermal matrix, per square centimeter
  • A2007

    Restrata, per square centimeter
  • A2008

    Theragenesis, per square centimeter
  • A2009

    Symphony, per square centimeter
  • A2010

    Apis, per square centimeter
  • A2011

    Supra sdrm, per square centimeter
  • A2012

    Suprathel, per square centimeter
  • A2013

    Innovamatrix fs, per square centimeter
  • A2014

    Omeza collagen matrix, per 100 mg
  • A2015

    Phoenix wound matrix, per square centimeter
  • A2016

    Permeaderm b, per square centimeter
  • A2017

    Permeaderm glove, each
  • A2018

    Permeaderm c, per square centimeter
  • A2019

    Kerecis omega3 marigen shield, per square centimeter
  • A2020

    Ac5 advanced wound system (ac5)
  • A2021

    Neomatrix, per square centimeter
  • A4100

    Skin substitute, fda cleared as a device, not otherwise specified
  • A4216

    Sterile water, saline and/or dextrose, diluent/flush, 10 ml
  • A4217

    Sterile water/saline, 500 ml
  • A4218

    Sterile saline or water, metered dose dispenser, 10 ml
  • A9581

    Injection, gadoxetate disodium, 1 ml
  • C7900

    Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, initial 15-29 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service
  • C7901

    Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, initial 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service
  • C7902

    Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, each additional 15 minutes, provided remotely by hospital staff who are licensed to provide mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service (list separately in addition to code for primary service)
  • C8957

    Intravenous infusion for therapy/diagnosis; initiation of prolonged infusion (more than 8 hours), requiring use of portable or implantable pump
  • C9094

    Inj, sutimlimab-jome, 10 mg
  • C9095

    Inj, tebentafusp-tebn, 1 mcg
  • C9096

    Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
  • C9097

    Inj, faricimab-svoa, 0.1 mg
  • C9098

    Ciltacabtagene autoleucel, up to 100 million autologous b-cell maturation antigen (bcma) directed car-positive t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
  • C9101

    Injection, oliceridine, 0.1 mg
  • C9121

    Injection, argatroban, per 5 mg
  • C9132

    Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
  • C9142

    Injection, bevacizumab-maly, biosimilar, (alymsys), 10 mg
  • C9145

    Injection, aprepitant, (aponvie), 1 mg
  • C9146

    Injection, mirvetuximab soravtansine-gynx, 1 mg
  • C9147

    Injection, tremelimumab-actl, 1 mg
  • C9148

    Injection, teclistamab-cqyv, 0.5 mg
  • C9149

    Injection, teplizumab-mzwv, 5 mcg
  • C9248

    Injection, clevidipine butyrate, 1 mg
  • C9285

    Lidocaine 70 mg/tetracaine 70 mg, per patch
  • C9290

    Injection, bupivacaine liposome, 1 mg
  • C9293

    Injection, glucarpidase, 10 units
  • C9399

    Unclassified drugs or biologicals
  • C9460

    Injection, cangrelor, 1 mg
  • C9738

    Adjunctive blue light cystoscopy with fluorescent imaging agent (list separately in addition to code for primary procedure)